整合影像组学与机器学习方法预测结直肠癌肝转移的RAS突变状态
本研究分析77个已知RAS突变状态的结直肠癌肝转移灶,从肝胆期MRI和门静脉期CT提取影像组学特征,经特征筛选后训练六种机器学习模型。梯度提升机(GBM)表现最佳,AUC达0.998,准确率95.6%。作者认为多参数影像组学有潜力作为无创的术前分子分层工具,但需在前瞻性多中心大样本队列中验证。
要点
- MRI衍生特征(小波变换gldm和一阶矩阵)个体AUC可达0.75以上。
- GBM模型AUC 0.998、准确率95.6%,随机森林AUC 0.990,CART AUC 0.914。
- 九个特征在所有模型中稳定位列前20位预测因子,提示稳健的模态非依赖性影像生物标志物。
核心结论
- 这项先导研究提示,联合CT和MRI的影像组学分析尤其经集成机器学习方法处理后,有潜力准确预测结直肠癌肝转移的RAS突变状态。
研究设计与样本
- 先导研究,分析77个已知RAS突变状态的结直肠癌肝转移灶(平均大小34.9 mm,范围17-56 mm),提取肝胆期MRI和门静脉期CT的影像组学特征。
临床应用与阅片要点
- 作者认为这些初步结果支持将多参数影像组学作为术前分子分层的潜在无创工具。
- 作者指出这些发现应谨慎解读,需在前瞻性多中心更大队列中验证模型的泛化能力。
局限性
- 患者队列小。
- 研究设计存在局限。
- 需在前瞻性多中心更大队列中验证以确认模型的泛化能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: RAS mutational status is a critical prognostic biomarker in colorectal liver metastases (CRLM), traditionally assessed via tissue biopsy. This study evaluates the potential of radiomic features extracted from CT and MRI to non-invasively predict RAS mutations using machine learning algorithms.
METHODS: In this study, 77 CRLM metastases (mean size 34.9; range 17-56 mm) with known RAS mutational status were analyzed. Radiomic features were extracted from hepatobiliary-phase MRI and portal venous-phase CT. After removing highly correlated features (Pearson |r| > 0.7) and applying z-score normalization, LASSO logistic regression with repeated tenfold cross-validation was used for feature selection. A total of 41 predictive features were identified. The dataset was split into training (70%) and testing (30%), ensuring that all lesions from a given patient were assigned exclusively to either the training or testing set. To address class imbalance in the training data, the Random Over Sampling Examples (ROSE) algorithm was applied exclusively to the training set. Six classification models (Stepwise Logistic Regression, LASSO, Random Forest, GBM, Neural Network, and CART) were trained and evaluated using ROC/AUC and other diagnostic metrics. DeLong's test was applied for pairwise AUC comparisons.
RESULTS: MRI-derived features, particularly from wavelet-transformed gldm and first-order matrices, showed strong predictive power, with several achieving > 0.75 AUC individually. The gradient boosting machine (GBM) outperformed all other models with an AUC of 0.998 and an accuracy of 95.6%. Random forest and CART also demonstrated high discriminative performance (AUCs of 0.990 and 0.914, respectively). Nine features were consistently ranked among the top 20 predictors across all models, suggesting robust modality-independent imaging biomarkers. DeLong's test confirmed statistically significant AUC differences between GBM and logistic regression models (p < 0.05).
CONCLUSIONS: The results of this pilot study suggest that radiomic analysis combining CT and MRI modalities, particularly when processed through ensemble machine learning methods, holds the potential to accurately predict RAS mutational status in CRLM. While promising, these findings should be interpreted with caution, considering the study's limitations, including the small patient cohort and its design. These factors highlight the need for prospective validation in larger, multicenter cohorts to confirm the generalizability of the models. Nevertheless, these preliminary results support the use of multiparametric radiomics as a potential non-invasive tool for preoperative molecular stratification.
引用
- Granata V, Fusco R, Setola SV, et al. Integrated radiomics and machine learning approach for ras mutation status prediction in colorectal liver metastases. Radiol Med. 2025. PMID: 41145899. doi:10.1007/s11547-025-02129-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。